Skip to main content

Table 3 Inhibition of cytokine release by VX-166 (n = 4 per assay).

From: VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis

Cytokine/cell type IC50 ± SD (nM)
IL-1β/LPS-treated human PBMC 260 ± 120
IL-18/SAC-treated human PBMC 450 ± 170
  1. IC50 = 50% inhibitory concentration; LPS = lipopolysaccharide; PBMC = peripheral blood mononuclear cells; SAC = Staphylococcus aureus cell suspension; SD = standard deviation.